
ABOUT US
Cytiva provides the expertise and tools spanning a wide range of applications from basic research of proteins and cells to large-scale purification of biopharmaceuticals. Within the bioprocessing space, Cytiva provides products and expertise for developers and manufacturers of biotherapeutics to enable efficient, flexible and cost-effective approaches to characterization, expression and purification of biomolecules. The company offers tools and support to take recombinant proteins, monoclonal antibodies, plasma proteins, oligonucleotides and vaccines from research, through process development, to full-scale manufacturing. Cytiva has a "healthymagination" vision for the future to improve quality, decrease costs and increase access to better healthcare around the world.
Bioprocessing: cell culture, chromatography and filtration solutions, and analytics
Cytiva's portfolio encompasses both upstream and downstream processing and includes solutions for large-scale production as well as tools for process development, Quality by Design, analytical analysis and flexible manufacturing. Some key product areas are listed below:
- ReadyToProcess™ - a platform of ready to use, and single use, flexible-manufacturing equipment, includes WAVE Bioreactor™ systems and Cellbag™ single-use cell culture bioreactors.
- Xcellerex™ - a single-use technologies platform including XDR bioreactors, XDM Quad Mixers, and related single-use assemblies
- PreDictor™ 96-well plates and PreDictor RoboColumn™ units for process development of chromatography separations
- ULTA™ filters for sterile filtration and clarification applications
- MabSelect SuRe™ LX, the Capto™ media family; and Capto ImpRes all modern BioProcess™ media for all phases of purification
- ÄKTA™ systems for all scales of chromatography and filtration
- AxiChrom™ chromatography columns
- Technical support, and training through Fast Trak services
Cytiva's products enable improvements in process efficiency through optimized performance, advanced automation, integrated unit operations, and technical support. These solutions allow agile manufacturing with shortened development times and excellent facility utilization. The company offers complete start-to-finish solutions in a range of areas such as monoclonal antibodies, plasma proteins, oligonucleotides and vaccines, and is continuously developing its range of products and services.
Additionally, Cytiva has a range of products for characterization and analysis of biomolecular interactions and biomolecule stability, including Biacore™ SPR and MicroCal™ DSC systems.
CONTACT INFORMATION
Cytiva
100 Results Way
Marlborough, MA 08855-1327
UNITED STATES
Phone: 800-526-3593
FEATURED PRODUCTS
- Hyclone Cell Boost Supplements
- HyClone Cell Culture Media, Sera And Process Liquids
- Label-Free Interaction Analytics
- Cell Culture Device: ReadyToProcess WAVE™ 25 Bioreactor System
- Single-Use, Flexible Stirred-Tank Bioreactor System: Xcellerex XDR-10
- Single-Use Anion Exchange Membranes: ReadyToProcess™ Adsorber Q
- Liquid Chromatography System For Scale-Up Biomanufacturing: ÄKTA
- Evaluation For Ultrafiltration To High Protein Concentration Using TFF
FEATURED ARTICLES
- Acepodia's Approach To ACC & CAR Manufacturing Scalability
- Effectively Managing Data In Process Development
- The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
- A Look Behind, A Look Ahead With Allan Shaw
- Process Considerations For Closed Connected Processing
- Lessons Learned Executing A Closed Connected Processing From Start To Finish
- How Clinical Trial Creativity Overcame COVID-19 Disruption
- Gene Therapy Manufacturing At-Scale With Geoff MacKay
- Bacterial Therapy: Modulation of the Microbiome
- Foundations Of Biopharma Finance With Smital Shah, MBA
- Off-The-Shelf CAR T-Cell Therapy?
- CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
- Cytiva’s Fibro PrismA Technology Accelerates mAb Purification In LifeArc’s Covid-19 Research
- A Model To Increase Yield In mAb Cell Culture Perfusion At Large Scale
- Using In-Line Sensors For Real-Time Control
- Developing A Closed Connected Single Use mAb Purification Process
- Gap Analysis With Dr Pablo Valenzuela & Cristián Hernández-Cuevas
- Developing A Continuous Large-Scale Perfusion Cell Culture Process
- Security Of Supply In Cell And Gene Therapy Manufacturing
- Drs. Edith Perez And Nathan Ihle: CMC Considerations For In-Human Studies
- Navigating Regulatory And Development Milestones
- Gap Analysis Fundamentals To Maintain Forward Progress
- CMC Considerations For First In-Human Studies
- The Relationship Between GMP And CMC - And The Team That Ties It Together
- The Data Quality & Master Files Challenge For FDA Submissions
- Commitment To GMP With Dr. Shabbir Anik
- Meeting The Process Development Challenges Of A Diverse Biologic Pipeline
- Data Quality For FDA Submissions With Dr. Robert Hariri
- Three Options To Viral Vector Manufacturing Capacity
- Dr. Gaurav Shah: Rocket's Chief Gene Therapist & Virtuoso
- Dr. Randy Schatzman On Dodging Disruption: The New Fundraising Norm
- Myeloid Cells, Transplants, & Immuno-Oncology Inspiration
- Considerations for improving outcome in biopharmaceutical process development
- Arrowhead Pharma's Dr. Christopher Anzalone: Taking RNAi Beyond The Liver
- Pluripotent Stem Cell Expansion And Scale-Up
- Improving Lentiviral Vector Downstream Processing Workflows
- The Role Of CDMOs In Cell And Gene Therapy Process Development
- Immunomedics' Dr. Loretta Itri On Taking ADCs Across The Finish Line
- Building A Biotech Around Your Therapeutic Platform
- Raise Your Upstream IQ: Process Development Optimization Considerations
- Solving The COVID-19 Workforce Crisis
- Bringing Big-League Finance Experience To An Emerging Biotech
- Leaving The Incubator With Kavitha Iyer Rodrigues
- Episode 6: Building An All-Star Biotech Team With Vivek Ramaswamy
- Is It Time To Leave The Biotech Incubator?
- Building An All-Star Biotech Team
- Finding Biotech Funding In Volatile Times
- Never Too Early To Plan For Automation
- Pitching Your Biotech To Investors
- Linking Biotech Value Creation And The Exit Strategy
- The Business Of Biotech
- Bridging The Skills Gap In Biopharma
- Episode 5: Finding Funding In Volatile Times With Ben Zeskind
- Episode 4: Building Your Pitch With Leslie Williams
- Business Continuity Program: Maintain Operations During Crises
- Approaches To Improve Efficiency In Biopharmaceutical Process Development
- Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader
- Is Not Using A CDMO Slowing Down Your Process Development?
- High-Throughput And Single-Use mAb Purification With Fibro Chromatography
- How Buffer pH And NaCl Affect Size Exclusion Chromatography
- Automated High Throughput mAb Purification Using Fibro Technology
- Episode 2: The Business Of Biotech: Allan Shaw
- Standardization Is Key To Building A Successful Global Business Strategy
- Episode 1: Introducing The Business Of Biotech Podcast
- The Evolution Of Supply Chain Security — Increased Focus On Raw Material Variability
- The Path To High-Quality Immunoassay Reagents
- Strategies To Address The Viral Vector Manufacturing Shortage
- Mechanistic Modeling Of Chromatography To Speed Up Process Development
- Raw Material Variability: The Need For Deeper Process Understanding
- Increasing Productivity In Hydrophobic Interaction Chromatography
- Expanding SPR Uses In Antibody Effector Function Determination
- Novel Analytics To Improve Bioprocessing And Validation Guideline Review
- Scale-Up Of CHO Cell Fed-Batch Cultures
- Effects Of Feeding Strategy On CHO Cell Performance In Fed-Batch Cultures
- Optimizing Cell Culture Media: Increase Titer With Maintained Protein Quality
- Enhanced Host Cell Protein Analysis In Biologics Manufacturing
- The Insource Vs. Outsource Dilemma
- Purifying Plasmid DNA Using A Modern Chromatography Resin
- Principles Of Immunogenicity Assessment Using Biacore T200 SPR System
- Purifying Tagged Proteins Using ÄKTA Go Protein Purification System
- Epitope Binning: A Critical Step In Antibody Selection
- Securing Today’s Biomanufacturing Supply Chain Using Transformative Supply
- Can You Trust A Machine For Downstream Bioprocess Buffer Preparation?
- Unexpected SEC Results – Can It Be Improved?
- Master Analytical SEC Running Conditions
- Quality Matters – SEC Analysis For Antibody Aggregates
- Leverage Machine Learning For Faster High Content Analysis
- DeltaVision OMX Flex Super-Resolution Microscope: Product Overview
- Chromatography Processes – Reducing Timelines And Improving Outcomes
- EDGE Confocal Imaging Technology
- Improving Cell Image Analysis Workflows Through Machine Learning
- Developing A New Biologic Drug: Regulatory Challenges And Considerations
- Scaling A mAb Production Process To A Single-Use Platform
- GE Healthcare Launches Super-Resolution Microscope
- An End-To-End, Semi-Continuous Process For mAb Production
- Optimizing Drug Safety And Efficacy Of Complex Next-Generation Biologics
- Best Practices For A Successful Bioprocess Technology Transfer
- Virus Safety For Continuous Processing
- Understanding And Controlling Raw Material Variation In Cell Culture Media
- Partnership Brings A Better Film For Single-Use Bioprocessing
- Purposeful Design, Development Of Next-Gen Single-Use Bioprocess Film
- How To Adapt Your Biomanufacturing Process To Maximize Production
- Intensified Chromatography Strategies
- Achieving Operational Efficiency In Today’s Fragmented Market
- 4 Steps Toward End-To-End Connected Manufacturing
- Securing Bioprocess Film Supply
- Cost Of Healthcare And Biopharma Implications
- Development Pathways For ATMPs: Virus Safety Challenges And Regulatory Perspective
- Benefits And Challenges Of Driving Modernization In Vaccine Development
- Addressing New Chromatography Challenges With Fiber Absorbents
- The Current Landscape For Developing Biosimilars In India
- CMC Strategies For A Bispecific Antibody Platform For Cancer Immunotherapy
- A Plasma Problem: Dwindling Supply In The Face Of A Growing Demand
- Process Effects On Drug Product Quality In Pharmaceutical Manufacturing—A Validated Measurement Process
- Quantitating Binding Similarities In IgG Fcγ Receptor Analysis
- Better Biotherapeutic Characterization For Improved Quality Control
- Selectivity In Size Exclusion Chromatography (SEC): It’s Much More Than Average Pore Diameter (Å)
- Your Strategy To Manufacture, No Longer A One-Size-Fits-All
- The Value Of Digital In Biopharma
- Translating Biopharma Knowledge To Cell And Gene Therapies
- Guidelines To Bring Your Biologic To Market: Are You Prepared?
- Modular Bioprocessing Alleviates Drug Manufacturing Woes
- ICH Q12 Updates: Increasing Efficiency Of Post-Approval Changes
- Developing A Scalable Process For Adenovirus Manufacturing
- 6 Regulatory Changes Affecting Bioprocessing In China
- A Common Sense Approach To Sustainability In The Biosimilar Business
- Critical Considerations About The Future Of Global Cell Culture Bioprocessing
- The Use Of Cell-Free Synthesis In The Future Of Modern Medicine
- Converting From ELISA To Biacore SPR Assays
- Sensitive And Reproducible SPR-Based Concentration And Ligand-Binding Analyses
- How Well Are Your HCP ELISAs Covered?
- Why, Why, Why… ELISA? A Look At The Benchmark HCP Assay
- End-To-End Process For Oncolytic Adenovirus Production
- Adenovirus Production In Single-Use Bioreactor System
- Bispecific Antibody Purification: Insights And Case Studies
- More Efficient Bispecific Antibody Purification With Fewer Steps
- Digital Manufacturing Of Biologics
- The New Age Of Digital Biomanufacturing
- Optimizing Process Efficiency In Upstream Manufacturing
- Dancing In The Bioprocessing Ballroom: Voices Of Experience
- Staying Flexible In Biomanufacturing
- Evolution Of Single-Use Bioprocessing Into BioPharm 4.0
- Utilizing External Collaboration To Accelerate Vaccine Development
- Industry 4.0 Connects Machines And Data
- Raw Material Variability Control: Where Do We Go From Here?
- Amgen’s Digital Transformation: Link Suppliers' Raw Material Data To Patients
- How Biopharma Is Capitalizing On The Antibody Boom
- Making The Business Case For Vaccine Manufacturing
- Embracing Biosimilars, They Are Here To Stay
- Why Invest In Emerging Markets Now